UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169

Sortiert nach

Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific

Vaccines (Basel), 2022-01, Vol.10 (1), p.112

2022

Link zum Volltext

Verfügbarkeit prüfen

Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis

Vaccines (Basel), 2023-08, Vol.11 (8), p.1322

2023

Link zum Volltext

Verfügbarkeit prüfen

Respiratory Syncytial Virus: New Challenges for Molecular Epidemiology Surveillance and Vaccination Strategy in Patients with ILI/SARI

Vaccines (Basel), 2021-11, Vol.9 (11), p.1334

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs

Vaccines (Basel), 2022-08, Vol.10 (9), p.1400

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Influenza Vaccination on the Burden of Severe Influenza in the Elderly: Spain, 2017-2020

Vaccines (Basel), 2023-06, Vol.11 (6), p.1110

2023

Link zum Volltext

Verfügbarkeit prüfen

Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis

Vaccines (Basel), 2022-12, Vol.10 (12), p.2092

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review

Vaccines (Basel), 2023-10, Vol.11 (10)

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong

Vaccines (Basel), 2023-10, Vol.11 (10), p.1605

2023

Link zum Volltext

Verfügbarkeit prüfen

The Impact and Vaccination Coverage of Seasonal Influenza among Children Aged 6-59 Months in China in 2017-2018: An Internet Panel Survey

Vaccines (Basel), 2022-04, Vol.10 (4), p.630

2022

Link zum Volltext

Verfügbarkeit prüfen

Phytoestrogen β -Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses

Vaccines (Basel), 2023-01, Vol.11 (2), p.228

2023

Link zum Volltext

Verfügbarkeit prüfen

Influenza Vaccination Implementation in Sri Lanka: A Cost-Effectiveness Analysis

Vaccines (Basel), 2023-05, Vol.11 (5), p.932

2023

Link zum Volltext

Verfügbarkeit prüfen

Phytoestrogen Iβ/I-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses

Vaccines (Basel), 2023-01, Vol.11 (2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990

Vaccines (Basel), 2023-11, Vol.11 (11), p.1646

Standaert, Baudouin

2023

Link zum Volltext

Verfügbarkeit prüfen

Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research

Vaccines (Basel), 2024-02, Vol.12 (3), p.232

2024

Link zum Volltext

Verfügbarkeit prüfen

Rollout of the 2022/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults

Vaccines (Basel), 2023-11, Vol.11 (12), p.1748

2023

Link zum Volltext

Verfügbarkeit prüfen

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions

Vaccines (Basel), 2023-06, Vol.11 (6), p.1066

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic

Vaccines (Basel), 2023-02, Vol.11 (2), p.331

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate

Vaccines (Basel), 2023-11, Vol.11 (11), p.1679

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. IVaccines/I 2023, I11/I, 990

Vaccines (Basel), 2023-10, Vol.11 (11)

Standaert, Baudouin

2023

Link zum Volltext

Verfügbarkeit prüfen

Respiratory Syncytial Virus Infection: Treatments and Clinical Management

Vaccines (Basel), 2023-02, Vol.11 (2), p.491

2023

Link zum Volltext

Verfügbarkeit prüfen

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population

Vaccines (Basel), 2022-08, Vol.10 (8), p.1360

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age

Vaccines (Basel), 2023-09, Vol.11 (10), p.1528

2023

Link zum Volltext

Verfügbarkeit prüfen

Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution

Vaccines (Basel), 2023-10, Vol.11 (11), p.1628

2023

Link zum Volltext

Verfügbarkeit prüfen

The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

Vaccines (Basel), 2022-08, Vol.10 (9), p.1386

2022

Link zum Volltext

Verfügbarkeit prüfen

Does Vaccine Confidence Mediate the Relationship between Vaccine Literacy and Influenza Vaccination? Exploring Determinants of Vaccination among Staff Members of Nursing Homes in Tuscany, Italy, during the COVID-19 Pandemic

Vaccines (Basel), 2023-08, Vol.11 (8), p.1375

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaVirology

KollektionIngenta

Zeitschrift / SerieVaccines

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)

Publikationsform

Artikel
(169)

Sprache

Englisch
(169)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Immunology
(158)
Life Sciences & Biomedicine
(157)
Medicine, Research & Experimental
(157)
Research & Experimental Medicine
(157)
Science & Technology
(157)
Vaccines
(149)
Influenza
(119)
Vaccination
(94)
Infections
(78)
Covid-19 Vaccines
(74)
Pandemics
(74)
Public Health
(74)
Covid-19
(70)
Immunization
(70)
Viruses
(69)
Coronaviruses
(63)
Influenza Vaccines
(62)
Severe Acute Respiratory Syndrome Coronavirus 2
(53)
Health Aspects
(45)
Older People
(40)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific

Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis

Respiratory Syncytial Virus: New Challenges for Molecular Epidemiology Surveillance and Vaccination Strategy in Patients with ILI/SARI

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs

Impact of Influenza Vaccination on the Burden of Severe Influenza in the Elderly: Spain, 2017-2020

Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis

Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review

Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong

The Impact and Vaccination Coverage of Seasonal Influenza among Children Aged 6-59 Months in China in 2017-2018: An Internet Panel Survey

Phytoestrogen β -Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses

Influenza Vaccination Implementation in Sri Lanka: A Cost-Effectiveness Analysis

Phytoestrogen Iβ/I-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990

Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research

Rollout of the 2022/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions

Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic

Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. IVaccines/I 2023, I11/I, 990

Respiratory Syncytial Virus Infection: Treatments and Clinical Management

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age

Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution

The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

Does Vaccine Confidence Mediate the Relationship between Vaccine Literacy and Influenza Vaccination? Exploring Determinants of Vaccination among Staff Members of Nursing Homes in Tuscany, Italy, during the COVID-19 Pandemic

Aktive Filter

Suchergebnisse filtern